Yahoo Finance

Microbion Corporation Announces FDA Has Granted Fast Track Designation to MBN-101 for the Adjunctive Treatment of Moderate and Severe Diabetic Foot Ulcer Infections

BOZEMAN, MT, and VANCOUVER, BC--(Marketwired - August 04, 2016) - Microbion Corporation ("Microbion") of Bozeman, MT, USA and Microbion Pharma Corp. of Vancouver, BC, Canada, specializing in the ...
Yahoo Finance

Microbion and Haisco Announce Equity Investment and Development & Commercialization Agreement for MBN-101 in China and Related Territories

BOZEMAN, MT and VANCOUVER, BC--(Marketwired - March 01, 2016) - Microbion Corporation ("Microbion") of Bozeman, MT, USA and Microbion Pharma Corp. of Vancouver, BC, Canada, today announced that ...
Yahoo Finance

Microbion Granted Qualified Infectious Disease Product (QIDP) Designation for Adjunctive Treatment of Moderate and Severe Diabetic Foot Infections From U.S. FDA for MBN-101

BOZEMAN, MT and VANCOUVER, BC--(Marketwired - May 26, 2016) - Microbion Corporation ("Microbion") of Bozeman, MT, USA and Microbion Pharma Corp. of Vancouver, BC, Canada, today announced that the U.S.
Odessa American

Microbion Corporation Receives Additional Funding Support from the Cystic Fibrosis Foundation to Speed Advancement of Inhaled Pravibismane

BOZEMAN, Mont. and VANCOUVER, BC, Feb. 22, 2021 /PRNewswire/ — Microbion Corporation of Bozeman, MT, and Microbion Pharma Corp. of Vancouver, BC (“Microbion”) today announced that it has received ...
Pharmabiz

Microbion's drug candidate pravibismane gets second US FDA orphan drug status for treatment of non-TB mycobacterial infections

Microbion Corporation, a clinical-stage pharmaceutical company developing a new class of therapeutic compounds to improve the lives of patients with rare and serious diseases, announced that the ...
Business Insider

Microbion Corporation Announces Generic Name for Lead Antimicrobial Compound: Pravibismane

BOZEMAN, Mont. and VANCOUVER, British Columbia, Oct. 25, 2019 /PRNewswire/ -- Microbion Corporation of Bozeman, MT, and Microbion Pharma Corp. of Vancouver, BC ("Microbion") today announced that the ...
MarketWatch

(PR) Microbion Announces Positive Topline Results from Phase 2 Study of Topical Pravibismane for Moderately Infected Diabetic Foot Ulcers

-- Study achieves primary endpoint, demonstrating safety and tolerability of 12-week treatment regimen with high-concentration of topical pravibismane -- High patient compliance observed with at-home ...
Yahoo Finance

Microbion Corporation Announces First Patient Treated in Phase 2a Orthopedic Infection Trial

BOZEMAN, MT, and VANCOUVER, BC--(Marketwired - June 16, 2016) - Microbion Corporation ("Microbion") of Bozeman, MT, USA and Microbion Pharma Corp. of Vancouver, BC, Canada, specializing in the ...
FOX8 Cleveland

Microbion Corp. Presents a Poster on Pravibismane's Activity Against Diabetic Foot Infection Patient Isolates

Poster highlights pravibismane's MIC activity in testing against aerobic and anaerobic pathogens isolated from diabetic foot infection patients Pravibismane demonstrated potent, broad-spectrum ...